Search Results - "Luketina, Hrvoje"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Treatment Decision-Making Processes in the Systemic Treatment of Ovarian Cancer: Review of the Scientific Evidence [26H]

    Treatment Decision-Making Processes in the Systemic Treatment of Ovarian Cancer: Review of the Scientific Evidence [26H] by Luketina, Hrvoje

    Published in Obstetrics and gynecology (New York. 1953) (01-05-2017)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD Consortium

    HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD Consortium by Braicu, Elena Ioana, Luketina, Hrvoje, Richter, Rolf, Cacsire Castillo-Tong, Dan, Lambrechts, Sandrina, Mahner, Sven, Concin, Nicole, Mentze, Monika, Zeillinger, Robert, Vergote, Ignace, Sehouli, Jalid

    Published in OncoTargets and therapy (11-09-2014)
    “…Hypoxia is a common phenomenon encountered in solid cancers, leading to chemotherapy resistance and therefore to aggressiveness of the disease. The homeostatic…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Treatment Decision-making Processes in the Systemic Treatment of Ovarian Cancer: Review of the Scientific Evidence

    Treatment Decision-making Processes in the Systemic Treatment of Ovarian Cancer: Review of the Scientific Evidence by LUKETINA, Hrvoje, FOTOPOULOU, Christina, LUKETINA, Ruzica-Rosalia, PILGER, Adak, SEHOULI, Jalid

    Published in Anticancer research (01-09-2012)
    “…The systemic treatment of epithelial ovarian cancer (OC) is one of the cornerstones in the multimodal management of advanced OC in both primary and recurrent…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients—results from the OVCAD study

    The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients—results from the OVCAD study by Nassir, Mani, Guan, Jun, Luketina, Hrvoje, Siepmann, Timo, Rohr, Irena, Richter, Rolf, Castillo-Tong, Dan Cacsire, Zeillinger, Robert, Vergote, Ignace, Van Nieuwenhuysen, Els, Concin, Nicole, Marth, Christian, Hall, Christina, Mahner, Sven, Woelber, Linn, Sehouli, Jalid, Braicu, Elena Ioana

    Published in Tumor biology (01-03-2016)
    “…Patients with epithelial ovarian cancer (EOC) are at high risk of tumor recurrence. Human epididymis protein 4 (HE4) has been shown to be overexpressed in EOC…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    HIFI[alpha] is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer--a study of the OVCAD consortium

    HIFI[alpha] is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer--a study of the OVCAD consortium by Braicu, Elena Ioana, Luketina, Hrvoje, Richter, Rolf, Castillo-Tong, Dan Cacsire, Lambrechts, Sandrina, Mahner, Sven, Concin, Nicole, Mentze, Monika, Zeillinger, Robert, Vergote, Ignace, Sehouli, Jalid

    Published in OncoTargets and therapy (01-01-2014)
    “…Purpose: Hypoxia is a common phenomenon encountered in solid cancers, leading to chemotherapy resistance and therefore to aggressiveness of the disease. The…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: